Products

When will the FDA approve Compass Pathways' COMP360 Psilocybin?

Prediction market on kalshi. If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.

Liquidity: $91.08. Resolves: 1/8/2028.

Blockcircle
Quantitative tools and real-time data for crypto and macro markets. Scorecards, trade signals, and research in one platform.
Trade
Whale AlphaPrediction AlphaPolitical AlphaInsider AlphaTrade Alpha
Discover
Momentum Trading EngineAsset Outperformer EngineMarket Reversal EngineAlpha Hunter SuiteMarket Analysis
Scorecards
Global Liquidity ScorecardMacroeconomic Risk ScorecardAltcoin Market Scorecard
Resources
Pulse DashboardEcosystem StatsTrending MarketsUser GuidesTrading CourseOpen SourceBlog and News
Company
About UsPricingInstitutionalContactTerms & ConditionsPrivacy Policy
© 2026 Blockcircle. All rights reserved.